Formulation and evaluation of ketorolac ocular pH-triggered in-situ gel

International Journal of Drug Development and Research

Volumn 2, Issue 3, 2010, Pages 459-467

  Parthiban, Kugalur Ganesan ^a   Manivannan, Rangasamy ^a   Kumar, Balasubramanium Senthil ^a   Ahasan, Mirza Beg ^a  

^a JKK Munirajah Medical Research Foundation   (India)

Author keywords

Differential scanning calorimetry; Draize test; In situ gel; In vitro diffusion study; Ketorolac

Indexed keywords

BENZALKONIUM CHLORIDE; CARBOPOL 940; HYDROXYPROPYLMETHYLCELLULOSE; KETOROLAC;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG QUALITY; DRUG SCREENING; DRUG SYNTHESIS; EYE IRRITATION; GEL; IN VITRO STUDY; PH; PH MEASUREMENT; SUSTAINED DRUG RELEASE;

EID: 78650787553     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Martin RG, Jolly RP, Megha B, Dharmesh MM. A pH-triggered In situ gel-forming ophthalmic drug delivery system for tropicamide. Drug Delivery technology 2007; 44-49-
2. Malhotra M, Mujumdar DK. In vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: A technical Note. AAPS Pharma sci 2006; E1-E6.
3. Flach AJ, Kraff MC, Sanders DR, Tanenbaum L. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on post surgical blood aqueous barrier. Arch Ophthalmol 1988; 106:480.483.
4. Fraser-Smith EB, Mathews TR. Effect of ketorolac on pseudomonas aeruginosa ocular infection in rabbits. J Ocul Pharmacol 1988; 4:101-109-
5. Flach AJ, Dolan BJ, Irvine AR. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudoaphakic cystoid macular edema. Am J Ophthalmol 1987; 103: 479-486.
6. Manjappa AS, Basavaraj K, Nanjwade, Manvi FV, Murthy RSR. Sustained ophthalmic in situ gel of ketorolac tromethamine rheology and in vivo Studies. Drug Development Research 2009; 70: 417-424.
7. Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release 2001; 73:205-211-
8. Arora R, srivastava AK, Rani M, Mishra B. Investigation on osmotic matrix tablets as controlled delivery system of ketorolac tromethamine. Acta pharmaceutical turcica 2002; 44; 87-96.
9. Chunjie WU, Hongyi QI, Chen W, Huang C. Preparation and evaluation of a carbopol /HPMC-based in situ gelling ophthalmic system for puerarin. The pharmaceutical society of Japan 2007; 127(1)183-191-
10. Abraham S, Furtado S, Bharath S, Basavaraj BV, Deveswaran R, Madhavan V. Sustained ophthalmic delivery of ofloxacin from an ionactivated in situ gelling system. Pak. J. Pharm. Sci 2009; 175-179-
11. Mohan EC, Kandukuri JM, Allenki V. Preparation and evaluation of in-situ gels for ocular drug delivery. Journal of Pharmacy Research 2009, 2(6), 1089-1094.
12. Hiremath SSP, Dasankoppa FS, Nadaf A, Jamakandi VG, Mulla JS, Sreenivas SA, Sholapur HN, Aezazahmed, Nanjundaswamy NG. Formulation and evaluation of a novel in situ gum based ophthalmic drug delivery system of linezolid. Sci pharm 2008; 76: 515-532.